Olevian Dane C, Pai Reetesh K
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA.
Appl Immunohistochem Mol Morphol. 2018 Apr;26(4):231-238. doi: 10.1097/PAI.0000000000000611.
Most major professional medical organizations advocate universal screening for Lynch syndrome in colorectal carcinoma; however, some allow for a selective screening approach based on clinicopathologic factors including assessment of histologic features of mismatch repair protein deficiency (MMRD). We performed a prospective evaluation for histopathologic features of MMRD in colorectal carcinomas that underwent universal screening for Lynch syndrome to evaluate the ability of histology to predict MMRD. In total, 947 resected colorectal carcinomas over a 5-year period were prospectively analyzed for histologic features of MMRD and for DNA mismatch repair protein abnormalities. Histologic features of MMRD were reported as present in 281 of 947 (30%) tumors with only 109 (39%) cases demonstrating MMRD by immunohistochemistry. Histologic features of MMRD had a sensitivity of 74% [95% confidence interval (CI), 66%-80%], specificity of 78% (95% CI, 75%-81%), positive predictive value of 39% (95% CI, 32%-44%), and negative predictive value of 94% (95% CI, 92%-96%). Histologic features of MMRD in left colon/rectal tumors had a significantly lower sensitivity of 56% (95% CI, 41%-77%) compared with right colon tumors (P=0.02). Histologic rereview identified that tumor-infiltrating lymphocytes (TILs) were most likely to be incorrectly reported as absent, and 72% of cases incorrectly assessed as lacking TILs demonstrated MMRD by immunohistochemistry. We demonstrate that histologic features of MMRD do not reliably predict the presence of MMRD by immunohistochemistry. Interpretative errors in the assessment of histologic features of MMRD occur, particularly for TILs and in tumors of the left colon/rectum.
大多数主要的专业医学组织主张对结直肠癌患者进行林奇综合征的普遍筛查;然而,一些组织允许基于临床病理因素采取选择性筛查方法,包括评估错配修复蛋白缺陷(MMRD)的组织学特征。我们对接受林奇综合征普遍筛查的结直肠癌患者的MMRD组织病理学特征进行了前瞻性评估,以评估组织学预测MMRD的能力。在5年期间,对947例切除的结直肠癌进行了前瞻性分析,以研究MMRD的组织学特征和DNA错配修复蛋白异常情况。947例肿瘤中有281例(30%)报告存在MMRD的组织学特征,其中只有109例(39%)通过免疫组化显示存在MMRD。MMRD的组织学特征敏感性为74%[95%置信区间(CI),66%-80%],特异性为78%(95%CI,75%-81%),阳性预测值为39%(95%CI,32%-44%),阴性预测值为94%(95%CI,92%-96%)。与右半结肠癌相比,左半结肠/直肠肿瘤中MMRD的组织学特征敏感性显著降低,为56%(95%CI,41%-77%)(P=0.02)。组织学复查发现,肿瘤浸润淋巴细胞(TILs)最容易被错误报告为不存在,72%被错误评估为缺乏TILs的病例通过免疫组化显示存在MMRD。我们证明,MMRD的组织学特征不能可靠地通过免疫组化预测MMRD的存在。在评估MMRD的组织学特征时会出现解释性错误,特别是对于TILs以及左半结肠/直肠的肿瘤。